Search research articles
Contact Us
Filters
Showing results (251-260 of 418) with videos related to
Page
of 42
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
JCO Oncology Practice
|
January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
BMC Cancer
|
March 26, 2005
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)
Giuseppe Maglietta, Angela Damato, Silvia Finotto, et al.
JAMA Network Open
|
February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
Daniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Breast (Edinburgh, Scotland)
|
November 13, 2016
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis
Marta Bonotto, Lorenzo Gerratana, Massimo Di Maio, et al.
EMBO Reports
|
February 27, 2024
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia
Emanuele Middonti, Elena Astanina, Edoardo Vallariello, et al.
BMJ Open
|
September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol
Silvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Page
of 42
Search research articles
Search
Showing results (251-260 of 418) with videos related to
Sort By:
Page
of 42
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
JCO Oncology Practice
|
January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
Breast (Edinburgh, Scotland)
|
October 2, 2023
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
Massimo Di Maio, Claudia Bighin, Francesco Schettini, et al.
BMC Cancer
|
March 26, 2005
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)
Giuseppe Maglietta, Angela Damato, Silvia Finotto, et al.
JAMA Network Open
|
February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
Daniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Breast (Edinburgh, Scotland)
|
November 13, 2016
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis
Marta Bonotto, Lorenzo Gerratana, Massimo Di Maio, et al.
EMBO Reports
|
February 27, 2024
A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia
Emanuele Middonti, Elena Astanina, Edoardo Vallariello, et al.
BMJ Open
|
September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol
Silvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Page
of 42